For millions of Americans with essential tremor, simple tasks like writing a note, putting on makeup or plugging in an appliance can be difficult. | For millions of Americans with essential tremor, ...
Encora's device is set to be available in the US via a prescription-only model.
Encora Therapeutics announced today that it has received FDA 510(k) clearance for its Encora X1 wrist-worn device.
The Encora X1 utilizes proprietary algorithms to analyze a patient’s tremor in real time. It delivers targeted stimulation to the wrist, modulating the neural pathways responsible for the tremor. The ...
SAN DIEGO, April 14, 2025--(BUSINESS WIRE)--Encora Therapeutics today announced that its abstract, Safety and Efficacy of a Wrist-worn Vibratory Stimulation Wearable for Upper Limb Tremor Reduction in ...
The acquisition strengthens Encora's digital engineering capabilities and expands its global footprint with new centers across India, Europe, and the Americas. SANTA CLARA, Calif., Feb. 6, 2025 ...
"It is my great honor to welcome Anand to Encora as our next CEO. His deep experience in fast-growing tech and in scaling global businesses through exponential growth, makes him the ideal leader for ...